Weill Institute researchers uncover basic cell pathway

May 24, 2011 By Krishna Ramanujan in Genetics

Although all cells in an organism have the same DNA, cells function differently based on the genes they express. While most studies of gene expression focus on activities in the cell's nucleus, a new Cornell study finds that processes outside the nucleus -- along the cell membrane -- also play important roles in gene expression.

The study, published in the May 1 issue of , uses , a simple with 6,000 genes, most of which are found in other organisms, including humans, making them excellent candidates for studying complex biological pathways. This paper focuses on pathways related to the Gal1 gene, which is highly researched for characterizing as a model to understand how gene expression is induced and repressed.

The Cornell researchers identified two proteins, Tup1 and Cti6, which form a complex that regulates transcription of the Gal1 gene, but only through interactions with a lipid found on the cell membrane. Tup1 is highly conserved, meaning it has been unchanged through evolution and is found in many organisms from yeast to humans.

"People just focus on the chromosomes inside the nucleus [when studying gene expression]," said lead author Bong-Kwan Han, a research associate at Cornell's Weill Institute for Cell and Molecular Biology, who co-authored the paper with Scott Emr, director of the Weill Institute. "We show that we also have to look at the cytoplasm," Han added.

The researchers propose that Cti6 and a complex of the proteins Cyc8 and Tup1 shuttle out of the cell's nucleus to the , where they bind to a lipid called PI(3,5)P2 and then further assemble into a Cti6-Cyc8-Tup1 complex. This complex then shuttles back into the nucleus where it binds to other protein structures and plays central roles in activating and repressing transcription, and activating a repressed GAL1 gene.

"Our findings may provide important insights to understand how human Tup1 proteins regulate in our body," said Han. A few years ago, other researchers reported that the Charcot-Marie-Tooth disorder, a neurodegenerative human disease, may be related to a gene that regulates levels of the PI(3,5)P2 lipid. Also, since human Tup1 proteins are known to play an important role in nerve development, the researchers wonder whether the relationship between the PI(3,5)P2 lipid and Tup1 discovered in this study may be a factor in the underlying mechanism in the Charcot-Marie-Tooth disorder.

Future studies may explore whether such lipids modulate transcriptional regulators in other contexts and whether there are more examples of such lipid-mediated signaling mechanisms that shuttle between the cytoplasm to regulate the nucleus function of transcriptional factors.

Provided by Cornell University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Genetics created May 20, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers identify new circadian clock component

Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.

Genetics created May 16, 2013 | popularity 3 / 5 (1) | comments 1 | with audio podcast

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Genetics created May 16, 2013 | popularity 5 / 5 (1) | comments 3 | with audio podcast

Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Experts urge caution over use of new genetic sequencing techniques

The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.